{"denoms":[{"counts":[{"groupId":"BG000","value":"43"}],"units":"Participants"}],"groups":[{"description":"Use of dasatinib (50 mg orally twice a day) in treatment of pts with previously treated malignant mesothelioma","id":"BG000","title":"Dasatinib"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"35","upperLimit":"81","value":"68"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"12"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"31"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"43"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"19"}]}],"title":"0 - Fully Active"},{"categories":[{"measurements":[{"groupId":"BG000","value":"24"}]}],"title":"1 - Ambulatory, restricted strenuous activity"}],"description":"Classifies patients according to their functional impairment. Scores range from 0 (fully active) to 5 (death).","paramType":"NUMBER","title":"ECOG Performance Score","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"36"}]}],"title":"Pleura"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"}]}],"title":"Peritoneum"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Other"}],"paramType":"NUMBER","title":"Site of origin","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"33"}]}],"title":"Epithelial"},{"categories":[{"measurements":[{"groupId":"BG000","value":"5"}]}],"title":"Biphasic"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Sarcomatoid"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"Not reported"}],"paramType":"NUMBER","title":"Histology","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"43"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"}]}],"title":"No"}],"paramType":"NUMBER","title":"Prior chemotherapy","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"6"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"37"}]}],"title":"No"}],"paramType":"NUMBER","title":"Prior radiation","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"23"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"20"}]}],"title":"No"}],"paramType":"NUMBER","title":"Prior surgery","unitOfMeasure":"participants"}]}